This study is currently not recruiting participants.

Type 1 Diabetes Extension Study Protocol ITN066AI

Study on Type 1 Diabetes Post-Treatment

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to look at people with type 1 diabetes that have completed drug treatment trials.

Detailed description of study

The purpose of this study is to look at people with type 1 diabetes that have completed drug treatment trials.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: type 1 diabetes
  • Age: 100 years or below
  • Gender: All

The purpose of this study is to investigate individuals with type 1 diabetes who have completed drug treatment trials. Type 1 diabetes is a condition where the body does not produce insulin, a hormone needed to allow sugar (glucose) to enter cells to produce energy.

Participants will undergo a series of assessments to evaluate their health status after completing previous drug treatment trials for type 1 diabetes.

  • Who can participate: Adults aged 18 and over with type 1 diabetes who have completed drug treatment trials are eligible to participate.
  • Study details: Participants will undergo assessments to evaluate their health status. These assessments will not involve any active treatment or medication.
Updated on 19 Feb 2024. Study ID: 1602007407

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team